Carcinoma: all 6,715 studies
Page 39 of 68. Open to participants first (1,140), then studies with results posted, then the rest; newest registration first within each.
- The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial CarcinomaStatus unknownNCT03877627Not applicable
- Hepatic Artery Infusion Pump for NPC Liver MetastasesCompletedNCT03876574Phase 1
- Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck CancerWithdrawnNCT03875053Not applicable
- SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell CarcinomaStatus unknownNCT03874741Phase 2
- Neoantigen-primed DC Vaccines Therapy for Refractory Lung CancerStatus unknownNCT03871205Phase 1
- HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCCActive, not recruitingNCT03869034Phase 2
- Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal DiseaseCompletedNCT03868020Early Phase 1
- Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular CarcinomaTerminatedNCT03867370Phase 1/2
- A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal CarcinomaCompletedNCT03866967Phase 2
- Thermal Ablation Followed by Immunotherapy for HCCStatus unknownNCT03864211Phase 1/2
- Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular CarcinomaStatus unknownNCT03857815Phase 2
- A Prospective Study of Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell CarcinomaStatus unknownNCT03857763Phase 2
- Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）Status unknownNCT03855384Phase 3
- Serial Epstein-Barr Virus DNA Surveillance in Nasopharyngeal Carcinoma PatientsActive, not recruitingNCT03855020
- IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.Status unknownNCT03854838Phase 2
- Probiotics in the Prevention of Hepatocellular Carcinoma in CirrhosisStatus unknownNCT03853928Not applicable
- Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study)CompletedNCT03852238
- The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT03851939Phase 2
- The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent HepatectomyStatus unknownNCT03851913Phase 3
- The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC)Status unknownNCT03851887Phase 2
- Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular CarcinomaCompletedNCT03851471Early Phase 1
- A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsCompletedNCT03849469Phase 1
- (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC)Status unknownNCT03848078Not applicable
- Significance of Contralateral Central Lymph Node Dissection in Unilateral cN0 Differentiated Thyroid Carcinoma.Status unknownNCT03845647Not applicable
- A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsActive, not recruitingNCT03845166Phase 1
- Hyperbaric Radiation Sensitization of Head and Neck CancersStatus unknownNCT03843671Phase 2
- Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular CarcinomaCompletedNCT03841201Phase 2
- FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid TumorsCompletedNCT03841110Phase 1
- GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT03840421Phase 3
- Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver TransplantationActive, not recruitingNCT03839706Not applicable
- Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma PatientsCompletedNCT03839602Phase 2
- Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical ResectionStatus unknownNCT03839550Phase 2
- Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular CarcinomaStatus unknownNCT03838796Not applicable
- Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine CarcinomaCompletedNCT03837977Phase 2
- Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal CarcinomaStatus unknownNCT03837808Phase 3
- Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.Status unknownNCT03837613
- Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive WomenWithdrawnNCT03834571Phase 2
- Living Well After Breast SurgeryCompletedNCT03834532Not applicable
- Nivolumab in Patients With Advanced Cutaneous Squamous Cell CarcinomaStatus unknownNCT03834233Phase 2
- Metformin in Combined With Cisplatin Plus Paclitaxel With Advanced Esophageal Squamous Cell Carcinoma (ECMTPneo)Status unknownNCT03833466Phase 2
- Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal CarcinomaStatus unknownNCT03830996
- TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced CancersCompletedNCT03829436Phase 1
- CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney CancerCompletedNCT03829111Phase 1
- Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological TumorsStatus unknownNCT03827837Phase 2
- A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular CarcinomaStatus unknownNCT03825705Phase 1/2
- hARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"Status unknownNCT03824691Phase 2
- ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTSStatus unknownNCT03822988
- A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell CarcinomaTerminatedNCT03818542Phase 1
- Phase 1b Study of CAR2Anti-CEA CAR-T Cell Hepatic Infusions for Pancreatic Carcinoma Patients With CEA+ Liver MetastasesTerminatedNCT03818165Phase 1
- A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCCStatus unknownNCT03817658Phase 2
- Safety and Efficacy of SCT200 in Patients With Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT03817567Phase 1/2
- Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck CarcinomaStatus unknownNCT03817307Not applicable
- Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCCActive, not recruitingNCT03813836Phase 2
- HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCCStatus unknownNCT03812783Phase 2
- Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCCStatus unknownNCT03812770Phase 2
- Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical ResectionTerminatedNCT03812562Early Phase 1
- Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed ChemotherapyStatus unknownNCT03811379Phase 2
- 3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal CarcinomaCompletedNCT03810274
- Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerTerminatedNCT03809624Phase 1
- A Study on the Angioarchitecture of Hepatocellular CarcinomaTerminatedNCT03808766Not applicable
- Radial Versus Femoral Access for Superselective Embolization of Hepatocellular CarcinomaStatus unknownNCT03807947Not applicable
- Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCCCompletedNCT03806218Not applicable
- HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)CompletedNCT03804593
- HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCCWithdrawnNCT03803254Phase 2
- Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung CancerTerminatedNCT03802058Phase 2
- The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell CarcinomaStatus unknownNCT03800953Phase 2
- Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell CarcinomaStatus unknownNCT03799744Phase 1
- Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell CancerCompletedNCT03798639Phase 1
- Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic.Status unknownNCT03798132
- A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.Status unknownNCT03794440Phase 2/3
- Immune Repertoire of Ovarian HGSCStatus unknownNCT03794115
- A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCCStatus unknownNCT03793725Phase 2
- The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular CarcinomaStatus unknownNCT03793322Phase 1
- Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven CriteriaWithdrawnNCT03791918Phase 3
- PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell CarcinomaStatus unknownNCT03791905Phase 2
- Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.Status unknownNCT03790059Not applicable
- Vaccination With Flt3L, Radiation, and Poly-ICLCCompletedNCT03789097Phase 1/2
- Prevalence of PD-L1 Expression in Patients With Advanced Urothelial CarcinomaCompletedNCT03788746
- Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral MucositisCompletedNCT03788499Not applicable
- Study to Evaluate Efficacy of PDR001 in Patients With Squamous Cell Carcinoma of the EsophagusStatus unknownNCT03785496Phase 2
- A Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsCompletedNCT03784677Phase 1
- Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral CavityActive, not recruitingNCT03784066Phase 1/2
- TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCCWithdrawnNCT03782831Phase 2
- HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCCWithdrawnNCT03780634Phase 2
- HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-BStatus unknownNCT03780049Phase 3
- Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal CarcinomatosisCompletedNCT03777943
- the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular CarcinomaStatus unknownNCT03777475Not applicable
- Post-marketing Surveillance on the Safety of CabometyxTM in Korean PatientsCompletedNCT03776123
- AFP Model and Liver Transplantation.CompletedNCT03775863
- A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed TumorsCompletedNCT03775850Phase 1
- Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.Status unknownNCT03775798
- Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven CriteriaWithdrawnNCT03775707Phase 2
- Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast CancerStatus unknownNCT03775525Phase 1
- HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCCStatus unknownNCT03775395Phase 3
- Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile CarcinomaStatus unknownNCT03774901Phase 2
- Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort StudyCompletedNCT03774862
- MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma or Cutaneous Squamous Cell CarcinomaWithdrawnNCT03773744Phase 1
- Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot TrialStatus unknownNCT03769285Phase 2
- Yliver as a Test to Early Diagnose HCCCompletedNCT03767764
- Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in MartiniqueCompletedNCT03766672